[go: up one dir, main page]

EP0640097A4 - Compositions and methods for vaccination against coronaviruses. - Google Patents

Compositions and methods for vaccination against coronaviruses.

Info

Publication number
EP0640097A4
EP0640097A4 EP93911185A EP93911185A EP0640097A4 EP 0640097 A4 EP0640097 A4 EP 0640097A4 EP 93911185 A EP93911185 A EP 93911185A EP 93911185 A EP93911185 A EP 93911185A EP 0640097 A4 EP0640097 A4 EP 0640097A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
vaccination against
against coronaviruses
coronaviruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93911185A
Other languages
German (de)
French (fr)
Other versions
EP0640097A1 (en
Inventor
Timothy J Miller
Sharon Klepfer
Albert Paul Reed
Elaine V Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0640097A1 publication Critical patent/EP0640097A1/en
Publication of EP0640097A4 publication Critical patent/EP0640097A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP93911185A 1992-05-08 1993-05-07 Compositions and methods for vaccination against coronaviruses. Withdrawn EP0640097A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US822171 1992-01-16
US88217192A 1992-05-08 1992-05-08
PCT/US1993/004384 WO1993023422A1 (en) 1992-05-08 1993-05-07 Compositions and methods for vaccination against coronaviruses

Publications (2)

Publication Number Publication Date
EP0640097A1 EP0640097A1 (en) 1995-03-01
EP0640097A4 true EP0640097A4 (en) 1997-01-15

Family

ID=25380027

Family Applications (2)

Application Number Title Priority Date Filing Date
EP93911185A Withdrawn EP0640097A4 (en) 1992-05-08 1993-05-07 Compositions and methods for vaccination against coronaviruses.
EP93911170A Withdrawn EP0640096A4 (en) 1992-05-08 1993-05-07 Universal coronavirus vaccine.

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP93911170A Withdrawn EP0640096A4 (en) 1992-05-08 1993-05-07 Universal coronavirus vaccine.

Country Status (5)

Country Link
EP (2) EP0640097A4 (en)
JP (2) JPH07508176A (en)
AU (2) AU678970B2 (en)
CA (2) CA2134898A1 (en)
WO (2) WO1993023422A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
CA2135200C (en) * 1992-05-08 2001-03-27 Timothy J. Miller Canine coronavirus s gene and uses therefor
CA2134898A1 (en) * 1992-05-08 1993-11-25 Timothy J. Miller Compositions and methods for vaccination against coronaviruses
AU721367B2 (en) * 1993-02-26 2000-06-29 Wyeth Holdings Corporation Canine coronavirus vaccine from feline enteric coronavirus
EP0612532A3 (en) * 1993-02-26 1998-02-04 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
FR2724385B1 (en) * 1994-08-29 1996-12-13 Rhone Merieux FELINE INFECTIOUS PERITONITIS VACCINE.
WO1997010347A1 (en) * 1995-09-15 1997-03-20 Howard John A Expression cassettes and methods for delivery of animal vaccines
US6033845A (en) * 1996-12-18 2000-03-07 Engene Biotechnologies Inc Specific diagnostic for feline infectious peritonitis antibodies
WO1999025838A1 (en) * 1997-11-14 1999-05-27 University Of Georgia Research Foundation, Inc. Compositions and methods to prevent turkey enteritis
WO2001009290A2 (en) * 1999-07-30 2001-02-08 Laboratorio Avi-Mex, S.A. De C.V. Avian infectious bronchitis virus serotype
FR2828405B1 (en) * 2001-08-09 2005-06-24 Virbac Sa ANTI-CORONAVIRUS VACCINE
WO2005010034A1 (en) * 2003-07-21 2005-02-03 Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health Soluble fragments of the sars-cov spike glycoprotein
US7605135B2 (en) * 2003-11-10 2009-10-20 The University Of Hong Kong Baicalin as a treatment for SARS infection
ITMI20111182A1 (en) * 2011-06-28 2012-12-29 Canio Buonavoglia VACCINE FOR CORONAVIRUS CANINO
WO2015143335A1 (en) * 2014-03-20 2015-09-24 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
CN113248576A (en) * 2020-02-12 2021-08-13 北京科兴中维生物技术有限公司 Nucleic acid vaccine for coronavirus and preparation method thereof
US20240009297A1 (en) * 2020-07-24 2024-01-11 Soligenix, Inc. Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses
CN113072626B (en) * 2021-04-25 2023-05-05 龙岩学院 Cat coronavirus S recombinant protein and preparation method thereof
CN113238048B (en) * 2021-05-11 2024-03-15 抗码(苏州)生物科技有限公司 Diagnostic markers and their use in differentiating between new coronavirus infection and new coronavirus inactivated vaccination
CN113292640B (en) * 2021-06-18 2021-12-24 国药中生生物技术研究院有限公司 A recombinant novel coronavirus RBD trimeric protein vaccine producing broad-spectrum cross-neutralizing activity, its preparation method and application
CN114478716B (en) * 2021-12-28 2024-05-28 梅州市人民医院(梅州市医学科学院) Polypeptide combination and application thereof in novel coronavirus antibody detection
CN114773487B (en) * 2022-05-31 2024-07-02 湖南大学 Influenza virus and novel coronavirus fusion recombinant protein vaccine immunogen and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023423A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Canine coronavirus s gene and uses therefor
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63123385A (en) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー Novel antigenically active protein and peptide and feline infectious peritonitis virus vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
DE69013512T2 (en) * 1989-08-22 1995-02-23 Veterinary Infectious Disease BEEF CORONAVIRUS POLYPEPTIDES AND VACCINE.
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023423A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Canine coronavirus s gene and uses therefor
WO1993023421A1 (en) * 1992-05-08 1993-11-25 Smithkline Beecham Corporation Universal coronavirus vaccine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
M.J.M. KOOLEN ET AL.: "Immunogenic peptide comprising a mouse hepatitis virus A59 B-Cell epitope and an influenza virus T-cell epitope protects against lethal infection", JOURNAL OF VIROLOGY, vol. 64, no. 12, 1990, pages 6270 - 6273, XP000608291 *
See also references of WO9323422A1 *
W.P.A. POSTHUMUS ET AL.: "analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus", JOURNAL OF VIROLOGY, vol. 64, no. 7, 1990, pages 3304 - 3309, XP000608290 *

Also Published As

Publication number Publication date
WO1993023421A1 (en) 1993-11-25
AU678971B2 (en) 1997-06-19
JPH07508176A (en) 1995-09-14
AU4241093A (en) 1993-12-13
WO1993023422A1 (en) 1993-11-25
EP0640096A1 (en) 1995-03-01
AU4240493A (en) 1993-12-13
EP0640096A4 (en) 1997-01-15
EP0640097A1 (en) 1995-03-01
JPH08501931A (en) 1996-03-05
CA2134898A1 (en) 1993-11-25
AU678970B2 (en) 1997-06-19
CA2135201A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
EP0640097A4 (en) Compositions and methods for vaccination against coronaviruses.
AP9300502A0 (en) Vaccine compositions
IL109056A0 (en) Vaccine compositions
EP0604433A4 (en) Composition and method for disease treatment.
EP0671937A4 (en) Pharmaceutical emulsion compositions.
EP0596962A4 (en) Therapeutic compositions and methods.
ZA929155B (en) Wound healing compositions and methods for preparing and using same.
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
EP0649304A4 (en) Composition and methods for decreasing muscle breakdown.
PL313979A1 (en) Vaccine composition
GB9326425D0 (en) Vaccine compositions
AU7008494A (en) Methods and compositions for (salmonella)-based vaccines
EP0603965A3 (en) Modified block copolymers and process for the preparation thereof.
GB9215233D0 (en) Vaccines
LTIP606A (en) Peptide compounds, method for the preparation and use thereof
GB9213559D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GR3020172T3 (en) Sterilant mixture and sterilization method.
LTIP608A (en) Peptide compounds, method for the preparation and use thereof
GB9524214D0 (en) Methods and compositions for hiv vaccination
GB9211081D0 (en) Vaccines
ZA93245B (en) Pharmaceutical bacteriocin compositions and methods for using the same
LTIP607A (en) Peptide compounds, method for the preparation and use thereof
HU00561A9 (en) Pharmaceutical bacteriocin compositions and methods for using the same
HU00563A9 (en) Pharmaceutical bacteriocin compositions and methods for using the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19941122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PFIZER INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19961128

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990719

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000302